KEGG   DRUG: Lumiliximab
Entry
D06463                      Drug                                   
Name
Lumiliximab (USAN/INN);
Gomiliximab (USAN)
Formula
C6850H10656N1824O2106S50
Exact mass
153764.8843
Mol weight
153860.21
Efficacy
Antiallergic, Antiasthmatic, Antineoplastic, Anti-CD23 antibody
  Type
Monoclonal antibody
Comment
Treatment of allergic asthma, allergic rhinitis, and chronic lymphocytic leukemia
Target
CD23 [HSA:2208] [KO:K06468]
  Pathway
hsa04640  Hematopoietic cell lineage
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    CD23
     D06463  Lumiliximab (USAN/INN)
Other DBs
CAS: 357613-86-6
PubChem: 47208119
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system